Treatment outcome of radiation therapy and concurrent targeted molecular therapy in spinal metastasis from renal cell carcinoma
Sangjoon Park, Kyung Hwan Kim, Woo Joong Rhee, Jeongshim Lee, Yeona Cho, Woong Sub Koom
Radiat Oncol J. 2016;34(2):128-134. Published online 2016 Jun 17 DOI: https://doi.org/10.3857/roj.2016.01718
Citations to this article as recorded by 
The Impact of Adjunct Medical Therapy on Survival after Spine Metastasis: A Systematic Review and Pooled Data Analysis
Lilly Groszman, Jonathan A. Hubermann, Paul Kooner, Nawaf Alamiri, Anthony Bozzo, Ahmed Aoude
Cancers.2024; 16(7): 1425. CrossRef
Effect of radiotherapy on local control and overall survival in spinal metastasis of non-small-cell lung cancer after surgery and systemic therapy
Shengdong Wang, Zehao Chen, Keyi Wang, Hengyuan Li, Hao Qu, Haochen Mou, Nong Lin, Zhaoming Ye
Bone & Joint Open.2024; 5(4): 350. CrossRef
The Outcome of Molecularly Targeted Therapy after Surgical Treatment of Spinal Metastasis
Shurei Sugita, Sawako Ogiso, Masanori Fujiwara, Euan Morita, Takuma Koyama, Takahiro Hozumi
Journal of Clinical Medicine.2023; 12(12): 3920. CrossRef
Efficacy and safety of tyrosine kinase inhibitors alone or in combination with radiation therapy for metastatic renal cell carcinoma
Shihua Wang, Weihua Jin, Changqing Jiang, Yiwen Zhang, Kaiwen Deng
Medicine.2021; 100(33): e27004. CrossRef
Stereotactic body radiation therapy for spinal metastases: a novel local control stratification by spinal region
Roman O. Kowalchuk, Michael R. Waters, K. Martin Richardson, Kelly Spencer, James M. Larner, William H. McAllister, Jason P. Sheehan, Charles R. Kersh
Journal of Neurosurgery: Spine.2021; 34(2): 267. CrossRef
Patient Characteristics Following Surgery for Spinal Metastases: A Multicenter Retrospective Study
Li Yang, Feng Wang, Hao Zhang, Xiong‐gang Yang, Hao‐ran Zhang, Ji‐kai Li, Rui‐qi Qiao, Guo‐chuan Zhang, Yong‐cheng Hu
Orthopaedic Surgery.2019; 11(6): 1039. CrossRef
Phase 1b multicenter study of the safety and efficacy of stereotactic body radiation therapy for extracranial renal cell carcinoma metastases in combination with tyrosine kinase inhibitors or checkpoint inhibitors (VOLGA STUDY).
N. V. Dengina, T. Mitin, S. V. Gamayunov, S. Safina, Yu. M. Kreinina, I. V. Tsimafeyeu
Malignant tumours.2019; 9(3): 57. CrossRef
Stereotactic body radiation therapy in combination with systemic therapy for metastatic renal cell carcinoma: a prospective multicentre study
Natalia Dengina, Timur Mitin, Sergey Gamayunov, Sufia Safina, Yuliya Kreinina, Ilya Tsimafeyeu
ESMO Open.2019; 4(5): e000535. CrossRef
The Challenges of Renal Cell Carcinoma Metastatic to the Spine: A Systematic Review of Survival and Treatment
C. Rory Goodwin, A. Karim Ahmed, Christine Boone, Nancy Abu-Bonsrah, Risheng Xu, Niccole Germscheid, Daryl R. Fourney, Michelle Clarke, Ilya Laufer, Charles G. Fisher, Chetan Bettegowda, Daniel M. Sciubba
Global Spine Journal.2018; 8(5): 517. CrossRef
Role of metastasis‐directed treatment in kidney cancer
Sarah P. Psutka, Viraj A. Master
Cancer.2018; 124(18): 3641. CrossRef
The 18F-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomes
Jinhyun Choi, Jun Won Kim, Tae Joo Jeon, Ik Jae Lee, Gayle E. Woloschak
PLOS ONE.2018; 13(9): e0204918. CrossRef
Role of Radiotherapy in the Treatment of Renal Cell Cancer: Updated and Critical Review
Vincenzo Fusco, Salvatore Parisi, Barbara d'Andrea, Michele Troiano, Maria Antonietta Clemente, Franco Morelli, Rocchina Caivano, Giuseppe Guglielmi
Tumori Journal.2017; 103(6): 504. CrossRef